Suchergebnisse - "Cowan, Kyra"

PubPharm (71)

51

Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys

enthalten in: mAbs | 2013

von Leabman, M. | Meng, Y. | Kelley, R. | +3

52

GW24-e2907Effects of RG7652, a fully human mAb against proprotein convertase subtilisin/kexin type 9, on LDL-c: a Phase I, randomised, double-blind, placebo-controlled, single- and multiple-dose study

enthalten in: Heart | 2013

von Tingley, W. | Luca, D. | Leabman, M. | +5

53

HGF as a circulating biomarker of onartuzumab treatment in patients with advanced solid tumors

enthalten in: Molecular cancer therapeutics | 2013

von Penuel, E. | Li, C. | Parab, V. | +9

54

On assay robustness : the importance of early determination and science-driven decision-making

enthalten in: Bioanalysis | 2013

von Cowan, K.

55

Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques

enthalten in: Molecular metabolism | 2013

von Li, S. | Kievit, P. | Robertson, A. | +13

56

On assay robustness: the importance of early determination and science-driven decision-making

enthalten in: Bioanalysis | 2013

von Cowan, K.

57

The assay design used for measurement of therapeutic antibody concentrations can affect pharmacokinetic parameters : Case studies

enthalten in: mAbs | 2012

von Fischer, S. | Yang, J. | Anand, B. | +5

58

Utilizing design of experiments to characterize assay robustness

enthalten in: Bioanalysis | 2012

von Cowan, K. | Erickson, R. | Sue, B. | +6

59

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration

enthalten in: mAbs | 2012

von Zheng, Y. | Tesar, D. | Benincosa, L. | +28

60

Utilizing design of experiments to characterize assay robustness

enthalten in: Bioanalysis | 2012

von Cowan, K. | Erickson, R. | Sue, B. | +6